Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Companies

Displaying 1..8 of 8 - per page
Order by
PALAU PHARMA is a newly created biopharmaceutical company devoted to the discovery and development of small molecules for the treatment of inflammatory and autoimmune conditions. More
Supernus Pharmaceuticals is a specialty pharmaceutical company specific expertise in developing differentiated products in collaboration with partners and for its own CNS product portfolio. More
Merz Pharmaceuticals: Market leader in antidementia prescription drugs, antiparkinson, liver and scar therapy. Merz Consumer Care: Self-medication products and dermato-pharmaceutical products. More
High Content Screening Services More
Nasal drug delivery company. More
Chakra Biotech More
Eisai Inc. is a seasoned strategic partner. More
Displaying 1..8 of 8 - per page
Order by

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Dementia del

Browse By

Research Partnership for Due Diligence Execution
EuroPLX 39 + 40
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2009 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us